Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,919 | -2,176 | -8,296 | -5,706 | -2,090 |
| Depreciation Amortization | 1 | 1 | 1 | 1 | N/A |
| Accounts payable and accrued liabilities | 954 | 77 | 105 | -495 | -437 |
| Other Working Capital | 2,381 | 1,241 | 668 | -701 | 18 |
| Other Operating Activity | -556 | -457 | 1,621 | 2,768 | 938 |
| Operating Cash Flow | $-2,139 | $-1,315 | $-5,900 | $-4,133 | $-1,572 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | 256 | 256 | 256 |
| Investing Cash Flow | $N/A | $N/A | $256 | $256 | $256 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,350 | 820 | 500 | N/A | N/A |
| Other Financing Activity | 556 | 247 | 4,763 | 4,828 | 4,399 |
| Financing Cash Flow | $1,906 | $1,067 | $5,263 | $4,828 | $4,399 |
| Beginning Cash Position | 294 | 294 | 676 | 676 | 676 |
| End Cash Position | 61 | 47 | 294 | 1,626 | 3,759 |
| Net Cash Flow | $-233 | $-248 | $-382 | $950 | $3,083 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,139 | -1,315 | -5,900 | -4,133 | -1,572 |
| Free Cash Flow | -2,139 | -1,315 | -5,900 | -4,133 | -1,572 |